Persistent Systems LtdNSE: PERSISTENT
Open the Persistent Systems Ltd page
Follow Persistent Systems LtdFree account. Get a note when Persistent Systems Ltd files.
Q2 FY27 earnings call · October 15, 2026

PERSISTENT Q2 FY27 Earnings Call: 26th Straight Quarter of Growth, Nagaro Deal Costs Weigh on PAT

Cofacto ResearchPublished October 15, 20267 min read
Quick summary

PERSISTENT held its Q2 FY27 earnings call on October 15, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

26th Straight Quarter of Growth, But Reported PAT Hit by Deal Costs

  • Revenue of $487.6M (Rs.46,639M) — up 7.8% QoQ, 20% YoY in USD and 30.3% YoY in INR, marking the 26th consecutive sequential quarter of growth in Q2 FY 2026-2027.
  • EBIT of Rs.6,977.2M at 15% margin — up 19.5% YoY but margin down 130 bps YoY; QoQ margin declined 100 bps.
  • Reported PAT of Rs.3,515.1M (margin 7.5%) — down 25.4% YoY, hit by Rs.1,853.4M of Nagaro transaction costs (~3.1% PAT impact); operating PAT was Rs.4,951.5M (10.6% margin, +5% YoY).
  • Net other income turned negative at Rs.131.2M — vs positive Rs.414.9M in Q1 FY 2026-2027, with a foreign exchange loss of Rs.455.8M.
  • Cash and investments of Rs.29,996.7M (~$315M) as of Sep 30, 2026; billed DSO improved to 50 days from 61 in Q1; ROCE (ex-cash) at 45.6% vs 43.6% in Q1.
  • ESG score improved to 83.3 for FY 2025-2026 (from 81.7) per SES, a SEBI-registered rating provider.

Softer Bookings vs Q1, But TTM Metrics Remain Strong

  • Q2 FY 2026-2027 TCV of $633.5M and ACV of $481M — softer than Q1 FY 2026-2027 (TCV $1.146B, ACV $536.8M); management cited macroeconomic slowdown, slower client decision-making, and Middle East dynamics.
  • YoY TCV growth of 4% vs the typical 15-16% — CEO Sandeep Kalra flagged this as below trend, but pointed to TTM TCV growth of 36.3% and TTM ACV growth of 21.9% as stronger underlying indicators.
  • New bookings TCV of $367.1M and ACV of $262.3M in Q2 FY 2026-2027.
  • Top client buckets grew strongly YoY — top 5 customers +38.9%, top 10 +29.9%, top 100 +21.6% in Q2 FY 2026-2027.
  • North America revenue grew 22.5% YoY — while Europe declined 8.5% due to two client-specific ramp-downs.
  • Growth driven by a large High-Tech deal and a BFSI vendor consolidation exercise — per CEO Sandeep Kalra; BFSI themes included vendor consolidation, data/AI readiness modernization, and AI-enabled mainframe modernization.

Outcome-Based AI Deals, New Partnerships, and Internal Tool Capitalization

  • Software Reinvention Services targets 50% faster product development and 25% faster time-to-market — and demonstrated a 45% cost reduction on existing products for a marquee software company; the construct is outcome-based with assured customer cost savings and a revenue share with a backstop, using Sasva to deflate labor, license, and cloud costs.
  • A $650M+, 6.5-year engagement with one of the largest technology companies — won in Q1 FY 2026-2027 for product development, support, and cloud operations; management guided that 75-80% of the deal would ramp by Q2 FY 2026-2027, now reflected in revenue realization.
  • AI partnerships expanded in Q2 FY 2026-2027 — Persistent joined Anthropic's Claude Partner Network and earned Microsoft's Agentic Business solution specialization; partner certifications reached 25,000 and AI certifications 58,000.
  • Intangible assets under development rose to 0.6% of Q2 FY 2026-2027 revenue — from 0.5% in Q1 FY 2026-2027, covering internal AI tools (Sasva, Iora, GenAI); CFO Vinit Teredesai guided Q3 FY 2026-2027 costs depend on feature development and may increase further.
  • 20% of mid-market ISVs are on the "bleeding edge" of AI adoption — per Sandeep Kalra, while BFSI and Healthcare Life Sciences adopt more slowly due to regulatory constraints; clients are also seeking token cost optimization via purpose-built small language models and token FinOps.
  • 36 years serving 300 software companies, including 9 of the top 10 technology companies — leveraging the Sasva platform and 3C architecture (Core, Context, Coordination).

Wage Hikes and Large-Deal Ramp Weigh on Margin; No Firm Recovery Timeline

  • QoQ margin bridge of −100 bps — wage hikes cost 180 bps (net 140 bps after lower ESOP), utilization 20 bps, and large-deal third-party tool amortization 90 bps; offset by 150 bps from lower SG&A and favorable currency.
  • 90 bps margin impact from the large deal ramp-up in Q2 FY 2026-2027 — CFO Vinit Teredesai guided this will gradually normalize over the next 2-3 quarters (Q3 FY 2026-2027 to Q1 FY 2027-2028) as revenue scales.
  • High Tech segment margins ~20% lower on incremental revenues — partly due to the new end-to-end ownership deal spanning 20 products, which also drove a ~Rs.900 crore sequential increase in intangibles.
  • Headcount of 29,598 (net add of 958) at end of Q2 FY 2026-2027; utilization at 85.8% (down 70 bps QoQ); TTM attrition at 11.9%.
  • Management declined to give a specific near-term margin recovery timeline — no firm forward guidance for FY 2026-2027 or FY 2027-2028, but reiterated an aspirational 16-17% margin goal (period unspecified).
  • Software license costs rose in Q1 and Q2 FY 2026-2027 — from large-deal ramp-ups and AI tool investments; management expects the trend to continue with the software reinvention practice, describing it as a potential profitability enhancer over the next several quarters.

~94% Share Capital Secured; Regulatory Clearances and Debt Refinancing Pending

  • ~94.04% of Nagaro share capital secured — management expects closure by Q4 CY 2026 or Q1 CY 2027, pending RBI and Austrian/Spanish FDI clearances; a more specific expectation of 4-8 weeks (Q3 FY 2026-2027) was given, with a merger squeeze-out targeting full integration within 5-6 months (Q1/Q2 FY 2027-2028).
  • Financing plan of USD 1.25 billion — including USD 450 million via equity or equity-linked instruments, with shareholder approval already received.
  • ~$50M total acquisition cost — $19-20M incurred in Q2 FY 2026-2027, with the remaining $25-30M over the next 3-4 quarters (through Q1-Q2 FY 2027-2028), covering investment banking fees, bridge loan costs, legal, regulatory filings, and travel; one-time expenses are weighing on reported EPS growth.
  • Nagaro's existing debt is a SOFR-linked revolving credit from five banks — currently under refinancing; for Persistent's own acquisition debt (yet to be raised), the assumed net cost was guided at 5-6% (period unspecified for timing of drawdown).
  • Minimal customer overlap supports cross-sell — only 10 shared accounts out of 200+ Nagaro clients vs 201 Persistent $1M+ clients, with complementary SAP and AI consulting capabilities; a cooperation agreement allows early synergy before formal closure.

Marquee Wins Across Hyperscaler, Insurance, and Healthcare; Next Update in Q3

  • A leading hyperscaler selected Persistent as preferred partner for its newly formed "forward deployed engineering" organization in Q2 FY 2026-2027, to scale legacy/mainframe modernization anchored in business outcomes rather than effort.
  • A Fortune 500 US insurer chose Persistent as AI-led modernization partner for personal lines policy administration in Q2 FY 2026-2027, rebuilding a cloud-native platform using Persistent's proprietary AI accelerators.
  • One of the largest US cancer research and treatment organizations selected Persistent in Q2 FY 2026-2027 to manage technology across its national network under a single delivery model.
  • Six awards at the ISG Provider Lens Awards 2026 — plus "Growth Honor of the Year" (annual revenue more than USD 1 to 5 billion category) at Everest Group Elevate 2026 for the second consecutive year, a Business World Sustainable Worlds Award 2026, and honors across seven categories at the People Matters Infinity Awards India 2026.
  • Estonia-based acquisition effective 1 July (Q2 FY 2026-2027) — part of a vendor consolidation exercise at a larger customer (beyond top 5); management cited a healthy pipeline and is hopeful of growing this account significantly.
  • Next progress update on the ongoing process in three months (Q3 FY 2026-2027) — per management's closing remarks; no revised guidance or specific new risks were offered in the closing segment.

Ask about this

Ask Cofacto a question about this call. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.